E-LIB Suche - Ergebnisse für: Garcia-Manero, G.

1

EFFICACY AND SAFETY OF LUSPATERCEPT VERSUS EPOETIN ALFA IN ..:

Garcia-Manero, G. ; Platzbecker, U. ; Santini, V....
Leukemia Research Reports. 21 (2024) - p. 100447 , 2024

Link: https://doi.org/10.1016/..

2

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III:..:

Savona, M. ; Mccloskey, J. ; Griffiths, E....
Leukemia Research. 128 (2023) - p. 107271 , 2023

Link: https://doi.org/10.1016/..

3

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:

Kuendgen, A. ; Nomdedeu, M. ; Tuechler, H....
Leukemia Research. 128 (2023) - p. 107226 , 2023

Link: https://doi.org/10.1016/..

4

Topic: AS08-Treatment/AS08b-Current treatment options – Low..:

Garcia-Manero, G. ; Bachiashvili, K. ; Amin, H....
Leukemia Research. 128 (2023) - p. 107263 , 2023

Link: https://doi.org/10.1016/..

5

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:

Pfeilstöcker, M. ; Tuechler, H. ; Ades, L....
Leukemia Research. 128 (2023) - p. 107230 , 2023

Link: https://doi.org/10.1016/..

6

SINGLE CELL DATA:

Ganan-Gomez, I. ; Chien, K. ; Adema, V....
Leukemia Research. 128 (2023) - p. 107084 , 2023

Link: https://doi.org/10.1016/..

7

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III:..:

Garcia-Manero, G. ; Bachiashvili, K. ; Griffiths, E....
Leukemia Research. 128 (2023) - p. 107270 , 2023

Link: https://doi.org/10.1016/..

8

P781: CLINICAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION..:

Garcia-Manero, G. ; Matsuno, R. K. ; McBride, A....
HemaSphere. 6 (2022) - p. 676-677 , 2022

Link: https://doi.org/10.1097/..

9

P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN ..:

Garcia-Manero, G. ; Bart, S. ; McCloskey, J. K....
HemaSphere. 6 (2022) - p. 663-664 , 2022

Link: https://doi.org/10.1097/..

10

P762: NONLINIEAR IMPACT OF CLINICAL FEATURES ON THE SURVIVA..:

Darbaniyan, F. ; Montalban Bravo, G. ; Chien, K. S....
HemaSphere. 6 (2022) - p. 657-658 , 2022

Link: https://doi.org/10.1097/..

11

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGI..:

Ravandi, F. ; Jabbour, E. ; Jain, N....
HemaSphere. 6 (2022) - p. 265-266 , 2022

Link: https://doi.org/10.1097/..

12

P765: UPDATED ENROLLMENT AND RESULTS FROM THE PHASE 1 SUBST..:

DiNardo, C. D. ; Foran, J. M. ; Watts, J. M....
HemaSphere. 6 (2022) - p. 660-661 , 2022

Link: https://doi.org/10.1097/..

13

P369: A PHASE II STUDY OF MINI-HYPER-CVD PLUS VENETOCLAX IN..:

Senapati, J. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 269-270 , 2022

Link: https://doi.org/10.1097/..

14

P566: IMPACT OF FRONTLINE INDUCTION APPROACH ON POST-STEM C..:

Ong, F. ; Ravandi, F. ; Popat, U....
HemaSphere. 6 (2022) - p. 465-466 , 2022

Link: https://doi.org/10.1097/..

15

P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHE..:

Hasegawa, K. ; Wei, A. H. ; Garcia-Manero, G....
HemaSphere. 6 (2022) - p. 669-670 , 2022

Link: https://doi.org/10.1097/..